Global Influenza Vaccine Supply, Demand and Key Producers, 2023-2029

Page: 127

Published Date: 18 Oct 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The global Influenza Vaccine market size is expected to reach $ 11570 million by 2029, rising at a market growth of 5.3% CAGR during the forecast period (2023-2029).

Global key players of Vaccine for Influenza include Sanofi, CSL and GSK, etc. The top five players hold a share about 75%. North America is the largest market, has a share about 50%.

This report studies the global Influenza Vaccine production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Influenza Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Influenza Vaccine that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Influenza Vaccine total production and demand, 2018-2029, (M Units)
Global Influenza Vaccine total production value, 2018-2029, (USD Million)
Global Influenza Vaccine production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (M Units)
Global Influenza Vaccine consumption by region & country, CAGR, 2018-2029 & (M Units)
U.S. VS China: Influenza Vaccine domestic production, consumption, key domestic manufacturers and share
Global Influenza Vaccine production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (M Units)
Global Influenza Vaccine production by Type, production, value, CAGR, 2018-2029, (USD Million) & (M Units)
Global Influenza Vaccine production by Application production, value, CAGR, 2018-2029, (USD Million) & (M Units).

This reports profiles key players in the global Influenza Vaccine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, CSL, GSK, Viatris, AstraZeneca, Hualan Bio, Changchun Institute of Biological, Sinovac and BCHT, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Influenza Vaccine market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (M Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Influenza Vaccine Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Influenza Vaccine Market, Segmentation by Type
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine

Global Influenza Vaccine Market, Segmentation by Application
6 Months to 3 Years
> 3 Years

Companies Profiled:
Sanofi
CSL
GSK
Viatris
AstraZeneca
Hualan Bio
Changchun Institute of Biological
Sinovac
BCHT
Jiangsu GDK
KM Biologics

Key Questions Answered
1. How big is the global Influenza Vaccine market?
2. What is the demand of the global Influenza Vaccine market?
3. What is the year over year growth of the global Influenza Vaccine market?
4. What is the production and production value of the global Influenza Vaccine market?
5. Who are the key producers in the global Influenza Vaccine market?

Table of Contents

1 Supply Summary
    1.1 Influenza Vaccine Introduction
    1.2 World Influenza Vaccine Supply & Forecast
        1.2.1 World Influenza Vaccine Production Value (2018 & 2022 & 2029)
        1.2.2 World Influenza Vaccine Production (2018-2029)
        1.2.3 World Influenza Vaccine Pricing Trends (2018-2029)
    1.3 World Influenza Vaccine Production by Region (Based on Production Site)
        1.3.1 World Influenza Vaccine Production Value by Region (2018-2029)
        1.3.2 World Influenza Vaccine Production by Region (2018-2029)
        1.3.3 World Influenza Vaccine Average Price by Region (2018-2029)
        1.3.4 North America Influenza Vaccine Production (2018-2029)
        1.3.5 Europe Influenza Vaccine Production (2018-2029)
        1.3.6 China Influenza Vaccine Production (2018-2029)
        1.3.7 Japan Influenza Vaccine Production (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Influenza Vaccine Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Influenza Vaccine Major Market Trends

2 Demand Summary
    2.1 World Influenza Vaccine Demand (2018-2029)
    2.2 World Influenza Vaccine Consumption by Region
        2.2.1 World Influenza Vaccine Consumption by Region (2018-2023)
        2.2.2 World Influenza Vaccine Consumption Forecast by Region (2024-2029)
    2.3 United States Influenza Vaccine Consumption (2018-2029)
    2.4 China Influenza Vaccine Consumption (2018-2029)
    2.5 Europe Influenza Vaccine Consumption (2018-2029)
    2.6 Japan Influenza Vaccine Consumption (2018-2029)
    2.7 South Korea Influenza Vaccine Consumption (2018-2029)
    2.8 ASEAN Influenza Vaccine Consumption (2018-2029)
    2.9 India Influenza Vaccine Consumption (2018-2029)

3 World Influenza Vaccine Manufacturers Competitive Analysis
    3.1 World Influenza Vaccine Production Value by Manufacturer (2018-2023)
    3.2 World Influenza Vaccine Production by Manufacturer (2018-2023)
    3.3 World Influenza Vaccine Average Price by Manufacturer (2018-2023)
    3.4 Influenza Vaccine Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Influenza Vaccine Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Influenza Vaccine in 2022
        3.5.3 Global Concentration Ratios (CR8) for Influenza Vaccine in 2022
    3.6 Influenza Vaccine Market: Overall Company Footprint Analysis
        3.6.1 Influenza Vaccine Market: Region Footprint
        3.6.2 Influenza Vaccine Market: Company Product Type Footprint
        3.6.3 Influenza Vaccine Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Influenza Vaccine Production Value Comparison
        4.1.1 United States VS China: Influenza Vaccine Production Value Comparison (2018 & 2022 & 2029)
        4.1.2 United States VS China: Influenza Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States VS China: Influenza Vaccine Production Comparison
        4.2.1 United States VS China: Influenza Vaccine Production Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Influenza Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States VS China: Influenza Vaccine Consumption Comparison
        4.3.1 United States VS China: Influenza Vaccine Consumption Comparison (2018 & 2022 & 2029)
        4.3.2 United States VS China: Influenza Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
    4.4 United States Based Influenza Vaccine Manufacturers and Market Share, 2018-2023
        4.4.1 United States Based Influenza Vaccine Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Influenza Vaccine Production Value (2018-2023)
        4.4.3 United States Based Manufacturers Influenza Vaccine Production (2018-2023)
    4.5 China Based Influenza Vaccine Manufacturers and Market Share
        4.5.1 China Based Influenza Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Influenza Vaccine Production Value (2018-2023)
        4.5.3 China Based Manufacturers Influenza Vaccine Production (2018-2023)
    4.6 Rest of World Based Influenza Vaccine Manufacturers and Market Share, 2018-2023
        4.6.1 Rest of World Based Influenza Vaccine Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Influenza Vaccine Production Value (2018-2023)
        4.6.3 Rest of World Based Manufacturers Influenza Vaccine Production (2018-2023)

5 Market Analysis by Type
    5.1 World Influenza Vaccine Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Trivalent Influenza Vaccine
        5.2.2 Quadrivalent Influenza Vaccine
    5.3 Market Segment by Type
        5.3.1 World Influenza Vaccine Production by Type (2018-2029)
        5.3.2 World Influenza Vaccine Production Value by Type (2018-2029)
        5.3.3 World Influenza Vaccine Average Price by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Influenza Vaccine Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 6 Months to 3 Years
        6.2.2 > 3 Years
    6.3 Market Segment by Application
        6.3.1 World Influenza Vaccine Production by Application (2018-2029)
        6.3.2 World Influenza Vaccine Production Value by Application (2018-2029)
        6.3.3 World Influenza Vaccine Average Price by Application (2018-2029)

7 Company Profiles
    7.1 Sanofi
        7.1.1 Sanofi Details
        7.1.2 Sanofi Major Business
        7.1.3 Sanofi Influenza Vaccine Product and Services
        7.1.4 Sanofi Influenza Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.1.5 Sanofi Recent Developments/Updates
        7.1.6 Sanofi Competitive Strengths & Weaknesses
    7.2 CSL
        7.2.1 CSL Details
        7.2.2 CSL Major Business
        7.2.3 CSL Influenza Vaccine Product and Services
        7.2.4 CSL Influenza Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.2.5 CSL Recent Developments/Updates
        7.2.6 CSL Competitive Strengths & Weaknesses
    7.3 GSK
        7.3.1 GSK Details
        7.3.2 GSK Major Business
        7.3.3 GSK Influenza Vaccine Product and Services
        7.3.4 GSK Influenza Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.3.5 GSK Recent Developments/Updates
        7.3.6 GSK Competitive Strengths & Weaknesses
    7.4 Viatris
        7.4.1 Viatris Details
        7.4.2 Viatris Major Business
        7.4.3 Viatris Influenza Vaccine Product and Services
        7.4.4 Viatris Influenza Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.4.5 Viatris Recent Developments/Updates
        7.4.6 Viatris Competitive Strengths & Weaknesses
    7.5 AstraZeneca
        7.5.1 AstraZeneca Details
        7.5.2 AstraZeneca Major Business
        7.5.3 AstraZeneca Influenza Vaccine Product and Services
        7.5.4 AstraZeneca Influenza Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.5.5 AstraZeneca Recent Developments/Updates
        7.5.6 AstraZeneca Competitive Strengths & Weaknesses
    7.6 Hualan Bio
        7.6.1 Hualan Bio Details
        7.6.2 Hualan Bio Major Business
        7.6.3 Hualan Bio Influenza Vaccine Product and Services
        7.6.4 Hualan Bio Influenza Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.6.5 Hualan Bio Recent Developments/Updates
        7.6.6 Hualan Bio Competitive Strengths & Weaknesses
    7.7 Changchun Institute of Biological
        7.7.1 Changchun Institute of Biological Details
        7.7.2 Changchun Institute of Biological Major Business
        7.7.3 Changchun Institute of Biological Influenza Vaccine Product and Services
        7.7.4 Changchun Institute of Biological Influenza Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.7.5 Changchun Institute of Biological Recent Developments/Updates
        7.7.6 Changchun Institute of Biological Competitive Strengths & Weaknesses
    7.8 Sinovac
        7.8.1 Sinovac Details
        7.8.2 Sinovac Major Business
        7.8.3 Sinovac Influenza Vaccine Product and Services
        7.8.4 Sinovac Influenza Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.8.5 Sinovac Recent Developments/Updates
        7.8.6 Sinovac Competitive Strengths & Weaknesses
    7.9 BCHT
        7.9.1 BCHT Details
        7.9.2 BCHT Major Business
        7.9.3 BCHT Influenza Vaccine Product and Services
        7.9.4 BCHT Influenza Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.9.5 BCHT Recent Developments/Updates
        7.9.6 BCHT Competitive Strengths & Weaknesses
    7.10 Jiangsu GDK
        7.10.1 Jiangsu GDK Details
        7.10.2 Jiangsu GDK Major Business
        7.10.3 Jiangsu GDK Influenza Vaccine Product and Services
        7.10.4 Jiangsu GDK Influenza Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.10.5 Jiangsu GDK Recent Developments/Updates
        7.10.6 Jiangsu GDK Competitive Strengths & Weaknesses
    7.11 KM Biologics
        7.11.1 KM Biologics Details
        7.11.2 KM Biologics Major Business
        7.11.3 KM Biologics Influenza Vaccine Product and Services
        7.11.4 KM Biologics Influenza Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.11.5 KM Biologics Recent Developments/Updates
        7.11.6 KM Biologics Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Influenza Vaccine Industry Chain
    8.2 Influenza Vaccine Upstream Analysis
        8.2.1 Influenza Vaccine Core Raw Materials
        8.2.2 Main Manufacturers of Influenza Vaccine Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Influenza Vaccine Production Mode
    8.6 Influenza Vaccine Procurement Model
    8.7 Influenza Vaccine Industry Sales Model and Sales Channels
        8.7.1 Influenza Vaccine Sales Model
        8.7.2 Influenza Vaccine Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Influenza Vaccine Production Value by Region (2018, 2022 and 2029) & (USD Million)
    Table 2. World Influenza Vaccine Production Value by Region (2018-2023) & (USD Million)
    Table 3. World Influenza Vaccine Production Value by Region (2024-2029) & (USD Million)
    Table 4. World Influenza Vaccine Production Value Market Share by Region (2018-2023)
    Table 5. World Influenza Vaccine Production Value Market Share by Region (2024-2029)
    Table 6. World Influenza Vaccine Production by Region (2018-2023) & (M Units)
    Table 7. World Influenza Vaccine Production by Region (2024-2029) & (M Units)
    Table 8. World Influenza Vaccine Production Market Share by Region (2018-2023)
    Table 9. World Influenza Vaccine Production Market Share by Region (2024-2029)
    Table 10. World Influenza Vaccine Average Price by Region (2018-2023) & (US$/Unit)
    Table 11. World Influenza Vaccine Average Price by Region (2024-2029) & (US$/Unit)
    Table 12. Influenza Vaccine Major Market Trends
    Table 13. World Influenza Vaccine Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (M Units)
    Table 14. World Influenza Vaccine Consumption by Region (2018-2023) & (M Units)
    Table 15. World Influenza Vaccine Consumption Forecast by Region (2024-2029) & (M Units)
    Table 16. World Influenza Vaccine Production Value by Manufacturer (2018-2023) & (USD Million)
    Table 17. Production Value Market Share of Key Influenza Vaccine Producers in 2022
    Table 18. World Influenza Vaccine Production by Manufacturer (2018-2023) & (M Units)
    Table 19. Production Market Share of Key Influenza Vaccine Producers in 2022
    Table 20. World Influenza Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
    Table 21. Global Influenza Vaccine Company Evaluation Quadrant
    Table 22. World Influenza Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2022
    Table 23. Head Office and Influenza Vaccine Production Site of Key Manufacturer
    Table 24. Influenza Vaccine Market: Company Product Type Footprint
    Table 25. Influenza Vaccine Market: Company Product Application Footprint
    Table 26. Influenza Vaccine Competitive Factors
    Table 27. Influenza Vaccine New Entrant and Capacity Expansion Plans
    Table 28. Influenza Vaccine Mergers & Acquisitions Activity
    Table 29. United States VS China Influenza Vaccine Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 30. United States VS China Influenza Vaccine Production Comparison, (2018 & 2022 & 2029) & (M Units)
    Table 31. United States VS China Influenza Vaccine Consumption Comparison, (2018 & 2022 & 2029) & (M Units)
    Table 32. United States Based Influenza Vaccine Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Influenza Vaccine Production Value, (2018-2023) & (USD Million)
    Table 34. United States Based Manufacturers Influenza Vaccine Production Value Market Share (2018-2023)
    Table 35. United States Based Manufacturers Influenza Vaccine Production (2018-2023) & (M Units)
    Table 36. United States Based Manufacturers Influenza Vaccine Production Market Share (2018-2023)
    Table 37. China Based Influenza Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Influenza Vaccine Production Value, (2018-2023) & (USD Million)
    Table 39. China Based Manufacturers Influenza Vaccine Production Value Market Share (2018-2023)
    Table 40. China Based Manufacturers Influenza Vaccine Production (2018-2023) & (M Units)
    Table 41. China Based Manufacturers Influenza Vaccine Production Market Share (2018-2023)
    Table 42. Rest of World Based Influenza Vaccine Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Influenza Vaccine Production Value, (2018-2023) & (USD Million)
    Table 44. Rest of World Based Manufacturers Influenza Vaccine Production Value Market Share (2018-2023)
    Table 45. Rest of World Based Manufacturers Influenza Vaccine Production (2018-2023) & (M Units)
    Table 46. Rest of World Based Manufacturers Influenza Vaccine Production Market Share (2018-2023)
    Table 47. World Influenza Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 48. World Influenza Vaccine Production by Type (2018-2023) & (M Units)
    Table 49. World Influenza Vaccine Production by Type (2024-2029) & (M Units)
    Table 50. World Influenza Vaccine Production Value by Type (2018-2023) & (USD Million)
    Table 51. World Influenza Vaccine Production Value by Type (2024-2029) & (USD Million)
    Table 52. World Influenza Vaccine Average Price by Type (2018-2023) & (US$/Unit)
    Table 53. World Influenza Vaccine Average Price by Type (2024-2029) & (US$/Unit)
    Table 54. World Influenza Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 55. World Influenza Vaccine Production by Application (2018-2023) & (M Units)
    Table 56. World Influenza Vaccine Production by Application (2024-2029) & (M Units)
    Table 57. World Influenza Vaccine Production Value by Application (2018-2023) & (USD Million)
    Table 58. World Influenza Vaccine Production Value by Application (2024-2029) & (USD Million)
    Table 59. World Influenza Vaccine Average Price by Application (2018-2023) & (US$/Unit)
    Table 60. World Influenza Vaccine Average Price by Application (2024-2029) & (US$/Unit)
    Table 61. Sanofi Basic Information, Manufacturing Base and Competitors
    Table 62. Sanofi Major Business
    Table 63. Sanofi Influenza Vaccine Product and Services
    Table 64. Sanofi Influenza Vaccine Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 65. Sanofi Recent Developments/Updates
    Table 66. Sanofi Competitive Strengths & Weaknesses
    Table 67. CSL Basic Information, Manufacturing Base and Competitors
    Table 68. CSL Major Business
    Table 69. CSL Influenza Vaccine Product and Services
    Table 70. CSL Influenza Vaccine Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 71. CSL Recent Developments/Updates
    Table 72. CSL Competitive Strengths & Weaknesses
    Table 73. GSK Basic Information, Manufacturing Base and Competitors
    Table 74. GSK Major Business
    Table 75. GSK Influenza Vaccine Product and Services
    Table 76. GSK Influenza Vaccine Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 77. GSK Recent Developments/Updates
    Table 78. GSK Competitive Strengths & Weaknesses
    Table 79. Viatris Basic Information, Manufacturing Base and Competitors
    Table 80. Viatris Major Business
    Table 81. Viatris Influenza Vaccine Product and Services
    Table 82. Viatris Influenza Vaccine Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 83. Viatris Recent Developments/Updates
    Table 84. Viatris Competitive Strengths & Weaknesses
    Table 85. AstraZeneca Basic Information, Manufacturing Base and Competitors
    Table 86. AstraZeneca Major Business
    Table 87. AstraZeneca Influenza Vaccine Product and Services
    Table 88. AstraZeneca Influenza Vaccine Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 89. AstraZeneca Recent Developments/Updates
    Table 90. AstraZeneca Competitive Strengths & Weaknesses
    Table 91. Hualan Bio Basic Information, Manufacturing Base and Competitors
    Table 92. Hualan Bio Major Business
    Table 93. Hualan Bio Influenza Vaccine Product and Services
    Table 94. Hualan Bio Influenza Vaccine Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 95. Hualan Bio Recent Developments/Updates
    Table 96. Hualan Bio Competitive Strengths & Weaknesses
    Table 97. Changchun Institute of Biological Basic Information, Manufacturing Base and Competitors
    Table 98. Changchun Institute of Biological Major Business
    Table 99. Changchun Institute of Biological Influenza Vaccine Product and Services
    Table 100. Changchun Institute of Biological Influenza Vaccine Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 101. Changchun Institute of Biological Recent Developments/Updates
    Table 102. Changchun Institute of Biological Competitive Strengths & Weaknesses
    Table 103. Sinovac Basic Information, Manufacturing Base and Competitors
    Table 104. Sinovac Major Business
    Table 105. Sinovac Influenza Vaccine Product and Services
    Table 106. Sinovac Influenza Vaccine Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 107. Sinovac Recent Developments/Updates
    Table 108. Sinovac Competitive Strengths & Weaknesses
    Table 109. BCHT Basic Information, Manufacturing Base and Competitors
    Table 110. BCHT Major Business
    Table 111. BCHT Influenza Vaccine Product and Services
    Table 112. BCHT Influenza Vaccine Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 113. BCHT Recent Developments/Updates
    Table 114. BCHT Competitive Strengths & Weaknesses
    Table 115. Jiangsu GDK Basic Information, Manufacturing Base and Competitors
    Table 116. Jiangsu GDK Major Business
    Table 117. Jiangsu GDK Influenza Vaccine Product and Services
    Table 118. Jiangsu GDK Influenza Vaccine Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 119. Jiangsu GDK Recent Developments/Updates
    Table 120. KM Biologics Basic Information, Manufacturing Base and Competitors
    Table 121. KM Biologics Major Business
    Table 122. KM Biologics Influenza Vaccine Product and Services
    Table 123. KM Biologics Influenza Vaccine Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 124. Global Key Players of Influenza Vaccine Upstream (Raw Materials)
    Table 125. Influenza Vaccine Typical Customers
    Table 126. Influenza Vaccine Typical Distributors
List of Figure
    Figure 1. Influenza Vaccine Picture
    Figure 2. World Influenza Vaccine Production Value: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Influenza Vaccine Production Value and Forecast (2018-2029) & (USD Million)
    Figure 4. World Influenza Vaccine Production (2018-2029) & (M Units)
    Figure 5. World Influenza Vaccine Average Price (2018-2029) & (US$/Unit)
    Figure 6. World Influenza Vaccine Production Value Market Share by Region (2018-2029)
    Figure 7. World Influenza Vaccine Production Market Share by Region (2018-2029)
    Figure 8. North America Influenza Vaccine Production (2018-2029) & (M Units)
    Figure 9. Europe Influenza Vaccine Production (2018-2029) & (M Units)
    Figure 10. China Influenza Vaccine Production (2018-2029) & (M Units)
    Figure 11. Japan Influenza Vaccine Production (2018-2029) & (M Units)
    Figure 12. Influenza Vaccine Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World Influenza Vaccine Consumption (2018-2029) & (M Units)
    Figure 15. World Influenza Vaccine Consumption Market Share by Region (2018-2029)
    Figure 16. United States Influenza Vaccine Consumption (2018-2029) & (M Units)
    Figure 17. China Influenza Vaccine Consumption (2018-2029) & (M Units)
    Figure 18. Europe Influenza Vaccine Consumption (2018-2029) & (M Units)
    Figure 19. Japan Influenza Vaccine Consumption (2018-2029) & (M Units)
    Figure 20. South Korea Influenza Vaccine Consumption (2018-2029) & (M Units)
    Figure 21. ASEAN Influenza Vaccine Consumption (2018-2029) & (M Units)
    Figure 22. India Influenza Vaccine Consumption (2018-2029) & (M Units)
    Figure 23. Producer Shipments of Influenza Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
    Figure 24. Global Four-firm Concentration Ratios (CR4) for Influenza Vaccine Markets in 2022
    Figure 25. Global Four-firm Concentration Ratios (CR8) for Influenza Vaccine Markets in 2022
    Figure 26. United States VS China: Influenza Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 27. United States VS China: Influenza Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Influenza Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. United States Based Manufacturers Influenza Vaccine Production Market Share 2022
    Figure 30. China Based Manufacturers Influenza Vaccine Production Market Share 2022
    Figure 31. Rest of World Based Manufacturers Influenza Vaccine Production Market Share 2022
    Figure 32. World Influenza Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 33. World Influenza Vaccine Production Value Market Share by Type in 2022
    Figure 34. Trivalent Influenza Vaccine
    Figure 35. Quadrivalent Influenza Vaccine
    Figure 36. World Influenza Vaccine Production Market Share by Type (2018-2029)
    Figure 37. World Influenza Vaccine Production Value Market Share by Type (2018-2029)
    Figure 38. World Influenza Vaccine Average Price by Type (2018-2029) & (US$/Unit)
    Figure 39. World Influenza Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 40. World Influenza Vaccine Production Value Market Share by Application in 2022
    Figure 41. 6 Months to 3 Years
    Figure 42. > 3 Years
    Figure 43. World Influenza Vaccine Production Market Share by Application (2018-2029)
    Figure 44. World Influenza Vaccine Production Value Market Share by Application (2018-2029)
    Figure 45. World Influenza Vaccine Average Price by Application (2018-2029) & (US$/Unit)
    Figure 46. Influenza Vaccine Industry Chain
    Figure 47. Influenza Vaccine Procurement Model
    Figure 48. Influenza Vaccine Sales Model
    Figure 49. Influenza Vaccine Sales Channels, Direct Sales, and Distribution
    Figure 50. Methodology
    Figure 51. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Sanofi
CSL
GSK
Viatris
AstraZeneca
Hualan Bio
Changchun Institute of Biological
Sinovac
BCHT
Jiangsu GDK
KM Biologics

Related Reports

Global Influenza Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Influenza Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 18 Oct 2023

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Influenza Vaccine market size was valued at USD 8056.5 million in 2022 and is forecast to a readjusted size of USD 11570 million by 2029 with a CAGR of 5.3% during review period.

Product Tags

Influenza Vaccine

Needle-Free Influenza Vaccine

Inhaled Nasal Influenza Vaccine

Children Influenza Vaccine

Injection Influenza Vaccine

Canine Influenza Vaccine

Equine Influenza Vaccine

Flu (Influenza) Vaccine

Trivalent Inactivated Influenza Vaccine

Inactivated Influenza Vaccine

Nasal Spray Influenza Vaccine

Pandemic Influenza Vaccine

Nasal Spray Live Attenuated Influenza Vaccine

Live Attenuated Influenza Vaccine (LAIV)

Split Influenza Vaccine

Adjuvanted Influenza Vaccine

Recombinant Influenza Vaccine

Influenza Vaccine (Split Virion), Inactivated, Quadrivalent

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>